“中国股票慢牛正在形成”！高盛：未来两年有望涨30%

Core Viewpoint - The report from Goldman Sachs indicates that a slow bull market for Chinese stocks is forming, with an expected 30% upside for the MSCI China Index over the next two years [3][7]. Group 1: Market Performance - Since the low point at the end of 2022, the MSCI China Index has rebounded by 80%, despite experiencing four significant downturns during this period [5]. - Recently, the Shanghai Composite Index has struggled to maintain its position above 3900 points, while the CSI 300 Index has seen a cumulative decline of nearly 3% from its peak on October 9 [5]. - In the Hong Kong market, the Hang Seng Index has retraced over 5% from its high on October 2, and the Hang Seng Tech Index has dropped nearly 12% [6]. Group 2: Future Outlook - Goldman Sachs suggests that despite potential pullbacks, investors should shift their mindset from "selling at highs" to "buying at lows" as the bull market unfolds [7]. - The firm predicts that by the end of 2027, the MSCI China Index will rise by approximately 30%, driven by a 12% trend in profit growth and a further 5% to 10% revaluation potential [7]. Group 3: Supporting Factors for the Bull Market - Four key factors are identified to support the continued rise of Chinese stocks: 1. A favorable policy environment is emerging, with demand-side stimulus measures aligned with the new five-year plan aimed at rebalancing economic growth and mitigating external risks [8]. 2. Accelerated economic growth in China is anticipated, driven by the AI boom, which is transforming corporate profit models, alongside counter-cyclical policies that reignite hopes for profit recovery [8]. 3. Current valuations of Chinese stocks are attractive, with the index's price-to-earnings ratio in the medium range and a continued discount compared to global stocks [8]. 4. Strong capital flows are expected, with a structural shift of domestic capital towards equities and renewed interest from global investors seeking diversification [8]. Group 4: Investment Strategy - In light of the slow bull market, Goldman Sachs advocates for an alpha-driven investment strategy focusing on "China's ten giants" (including Tencent, Alibaba, Xiaomi, BYD, Meituan, NetEase, Midea, Hengrui Medicine, Ctrip, and Anta), "AI themes," "global leaders," "counter-cyclical beneficiaries," and "small-cap growth stocks in A-shares" [9].